Intercalating and Maintenance Gefitinib in Combination With Chemotherapy for Advanced EGFR-mutant NSCLC

Clinical trial NCT02299765 · TERMINATED

Trial details

NCT number: NCT02299765
Sponsor: Sichuan University
Status: TERMINATED
Phase: Phase 4
Study type: INTERVENTIONAL

Non-small Cell Lung Cancer Metastatic EGFR Activating Mutation

Start date: 2014-12-01
Primary completion: 2017-10-01
Enrollment: 61

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.